QIAGEN also reaffirmed its Q2 2024 forecast of net sales of at least $495M CER, with adjusted diluted EPS of $0.52 CER.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback